20.05.2026, 20:55
Kazakhstan's PollenVax vaccine for wormwood allergy could reach market by 2030-2032
ASTANA. May 20 (Interfax-Kazakhstan) - Kazakh scientists are developing what they say is the world's first recombinant allergy vaccine, PollenVax, against wormwood pollen, with the vaccine potentially reaching the market by 2030-2032, the National Agriculture Scientific and Educational Center said.
To read the full news articles, Subscribe.
May 26, 2026, 05:52PM
Putin preparing to visit Kazakhstan - Peskov
May 26, 2026, 05:18PM
Kazakhstan, IAEA sign roadmap for long-term nuclear cooperation through 2036
May 26, 2026, 05:13PM
Kazakhstan, Russia working on terms to boost oil transit to China
May 26, 2026, 05:06PM
Tokayev tells IAEA chief Kazakhstan committed to strengthening nuclear security
May 26, 2026, 03:56PM
AVERAGE WEIGHTED RATE ON MAY 26, 2026 IS 477.48 TENGE FOR $1; OFFICIAL QUOTATION FOR MAY 26, 2026 IS 472.48 TENGE FOR $1
May 26, 2026, 03:33PM
Putin reaffirms need for unity of CSTO members
May 26, 2026, 02:54PM
Kazakhstan-Russia trade could top $30 billion in 2026 - envoy
May 26, 2026, 02:51PM
First Kazakh nuclear power plant in final approval stage - Russian envoy
May 26, 2026, 02:46PM
Russian envoy: 'There will be plenty to talk about and more than a few surprises'
May 26, 2026, 02:27PM
Russia ready to pump more Kazakh oil via CPC - ambassador
May 26, 2026, 01:45PM
Magnitude 2 earthquake recorded in northern Kazakhstan
May 26, 2026, 01:38PM
Kazakhstan blocks nearly 7,000 internet resources with harmful content for children since start of year
May 26, 2026, 01:32PM
More than 35,000 foreign students studying at Kazakh universities – education minister
May 26, 2026, 01:20PM
Kazakhstan plans summer recreation for more than 3 mln children
May 26, 2026, 01:13PM
Interfax-Kazakhstan issues its 1111th Oil&Gas Report
Archive
